AnalystsDane LeoneDane Leone's Stock Forecasts
AnalystsDane Leone
Analyst Ranking
Bottom 4%
#4700 out of 4870 analysts
Average Return
-15.46%
Win Rate
31%21 out of 67
Risk vs Reward
Poor
Good
Dane Leone's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +159.44% | $21.25 | $55.13 | 2023-11-16 - 2024-11-15 | Buy |
Nkarta IncNKTX | +136.29% | $2.48 | $5.86 | 2023-06-28 - 2024-06-27 | Buy |
Kite Pharma IncKITE | +105.43% | $86.67 | $178.05 | 2017-06-08 - 2017-08-28 | Strong Buy |
Blueprint Medicines CorpBPMC | +95.28% | $46.22 | $90.26 | 2023-02-17 - 2024-02-16 | Strong Buy |
Bluebird Bio IncBLUE | +83.73% | $1,010.20 | $1,856.00 | 2016-02-29 - 2017-03-01 | Strong Buy |
Dane Leone Analyst Color
Get additional color on Dane Leone's coverage of popular stocks
Dane Leone's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Xilio Therapeutics IncXLO | 3 | Buy | $4.00 | +429.80% | Maintains | 6 months ago |
Regenxbio IncRGNX | 2 | Buy | $45.00 | N/A | Reinstates | a year ago |
Blueprint Medicines CorpBPMC | 4 | Strong Buy | $100.00 | N/A | Maintains | a year ago |
Revolution Medicines IncRVMD | 1 | Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Bluebird Bio IncBLUE | 6 | Buy | $260.00 | N/A | Maintains | a year ago |
Regeneron Pharmaceuticals IncREGN | 5 | Buy | $950.00 | N/A | Upgrades | a year ago |
LianbioLIANY | 3 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Nkarta IncNKTX | 5 | Strong Buy | $13.00 | N/A | Upgrades | 2 years ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $46.00 | N/A | Maintains | 2 years ago |
Galapagos NvGLPG | 4 | Buy | $69.00 | N/A | Upgrades | 2 years ago |
G1 Therapeutics IncGTHX | 4 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Relay Therapeutics IncRLAY | 2 | Strong Buy | $29.00 | N/A | Upgrades | 2 years ago |
Seagen IncSGEN | 3 | Strong Buy | $175.00 | N/A | Upgrades | 2 years ago |
Compass Therapeutics IncCMPX | 2 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Ocular Therapeutix IncOCUL | 3 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Xencor IncXNCR | 2 | Strong Buy | $58.00 | N/A | Upgrades | 3 years ago |
Simulations Plus IncSLP | 2 | Buy | $70.00 | N/A | Maintains | 3 years ago |
Allogene Therapeutics IncALLO | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cytokinetics IncCYTK | 2 | Buy | $63.00 | N/A | Maintains | 3 years ago |
Bristol Myers Squibb CoBMY | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Ayala Pharmaceuticals IncAYLA | 2 | Buy | $6.00 | N/A | Maintains | 3 years ago |
Curis IncCRIS | 1 | Buy | $300.00 | N/A | Initiates Coverage On | 4 years ago |
Tarsus Pharmaceuticals IncTARS | 2 | Strong Buy | $65.00 | N/A | Maintains | 4 years ago |
Sage Therapeutics IncSAGE | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Amgen IncAMGN | 3 | Buy | $255.00 | N/A | Upgrades | 5 years ago |
Celgene CorpCELG | 2 | Hold | N/A | N/A | Assumes | 6 years ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | $32.00 | N/A | Assumes | 7 years ago |
Kite Pharma IncKITE | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Johnson & JohnsonJNJ | 1 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Juno Therapeutics IncJUNO | 1 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.